Patents by Inventor Renee C. Roemmele

Renee C. Roemmele has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20180147186
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: January 24, 2018
    Publication date: May 31, 2018
    Applicant: IGNYTA, INC.
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • Bendamustine derivatives and methods of using same
    Patent number: 9913827
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: March 13, 2018
    Assignee: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. LaBell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20170182008
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: March 10, 2017
    Publication date: June 29, 2017
    Applicant: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. LaBell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • Bendamustine derivatives and methods of using same
    Patent number: 9630926
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: April 25, 2017
    Assignee: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. LaBell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20160289198
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: June 16, 2016
    Publication date: October 6, 2016
    Applicant: Ignyta, Inc.
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • Bendamustine derivatives and methods of using same
    Patent number: 9452988
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: November 12, 2013
    Date of Patent: September 27, 2016
    Assignee: Ignyta, Inc.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. Labell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele, Bradley McIntyre
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20160016912
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: September 28, 2015
    Publication date: January 21, 2016
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • Bendamustine derivatives and methods of using same
    Patent number: 9149464
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: October 6, 2015
    Assignee: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. Labell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • Bendamustine derivatives and methods of using same
    Patent number: 9150517
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: October 6, 2015
    Assignee: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. Labell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20150274675
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: November 12, 2013
    Publication date: October 1, 2015
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. Labell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20150246023
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: May 13, 2015
    Publication date: September 3, 2015
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20150232427
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: April 29, 2015
    Publication date: August 20, 2015
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • 2-aryl-5,6-dihydropyrimidinones and herbicidal use thereof
    Patent number: 5629264
    Abstract: A class of 2-aryl-5,6-dihydropyrimidinones and compositions thereof which are useful in the control of weeds is of the general formula ##STR1## wherein Ar is a substituted or unsubstituted aryl or heteroaryl;R.sup.3 is an optionally substituted alkyl, alkenyl or alkynyl;R.sup.5a and R.sup.5b are each independently a hydrogen atom, halo, cyano or an optionally substituted alkyl, alkenyl, alkynyl, alkoxy or alkylthio;R.sup.6a and R.sup.6b are each independently a hydrogen atom, halo, cyano, an optionally substituted alkyl, alkenyl, alkynyl, alkoxy or alkylthioalkyl, cycloalkyl, optionally substituted aryl, aryloxy, heterocyclyl or aralkyl, alkylamino, dialkylamino or dialkylaminocarbonyl;R.sup.5a and R.sup.6a taken together with the carbon atoms to which they are attached may form a fused 4-7 member ring containing 2-5 methylenes; andX is an oxygen or a sulfur atom.
    Type: Grant
    Filed: March 23, 1995
    Date of Patent: May 13, 1997
    Assignee: Rohm and Haas Company
    Inventors: Colin M. Tice, Lois M. Bryman, Renee C. Roemmele
  • 2-arylpyrimidines and herbicidal use thereof
    Patent number: 5453414
    Abstract: A class of 2-arylpyrimidines which is useful in the control of weeds of the general formula: ##STR1## wherein R.sup.2 is an optionally substituted aromatic ring; R.sup.3 is a saturated or unsaturated alkyl group; R.sup.5 is selected from acyl, alkoxyalkyl, alkoxyimino, dialkoxyalkyl, formyl, hydroxyalkyl, and hydroxyimino; R.sup.6 is selected from hydrogen, halo, alkyl, haloalkyl, aryl, and alkoxy; and X is oxygen or sulfur.
    Type: Grant
    Filed: January 18, 1994
    Date of Patent: September 26, 1995
    Assignee: Rohm and Haas Company
    Inventors: Colin M. Tice, Vincent A. Musco, Renee C. Roemmele, Harlow L. Warner